As part of their ongoing research efforts and to bring the most innovative investigative alternatives to our patients, cardiologists at University Hospitals of Cleveland are exploring the use of new medications and non-surgical techniques for the treatment of cardiovascular disease. To date, the only treatment available has been rhythm-controlling medications, which are often ineffective. The cardiology team at University Hospitals has long been a national leader in the treatment of arrhythmias. University Hospitals was chosen as one of only 20 sites throughout the world for an important clinical trial of a new medication, Hirulog, a potent anticoagulant for treatment unstable angina patients. Patients here were among only 2,000 worldwide to receive the medication, which now has proven itself to be a safer alternative to the commonly used blood thinner heparin.
Sheer stress can cause blood particles to become viscous, leading to arterial blockages.